Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Milton Charles Weinstein, PH.D.

TitleHenry J Kaiser Professor of Health Policy and Management
InstitutionHarvard School of Public Health
DepartmentHealth Policy and Management
Address718 Huntington Ave
Harvard Schl. of Public Health
718 Huntington Ave
Boston MA 02115
Phone617/432-0805
Other Positions
TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. McGarry LJ, Krishnarajah G, Hill G, Masseria C, Skornicki M, Pruttivarasin N, Arondekar B, Roiz J, Pelton SI, Weinstein MC. Cost-Effectiveness of Tdap Vaccination of Adults Aged =65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission. PLoS One. 2014; 9(1):e72723.
    View in: PubMed
  2. Pandya A, Weinstein MC, Salomon JA, Cutler D, Gaziano TA. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines. Circ Cardiovasc Qual Outcomes. 2014 Jan 1; 7(1):25-32.
    View in: PubMed
  3. Ciaranello AL, Morris BL, Walensky RP, Weinstein MC, Ayaya S, Doherty K, Leroy V, Hou T, Desmonde S, Lu Z, Noubary F, Patel K, Ramirez-Avila L, Losina E, Seage Iii GR, Freedberg KA. Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection. PLoS One. 2013; 8(12):e83389.
    View in: PubMed
  4. Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013 Oct 31; 369(18):1715-25.
    View in: PubMed
  5. Lawrence D, Maschio M, Leahy KJ, Yunger S, Easaw JC, Weinstein MC. Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC). J Med Econ. 2013 Dec; 16(12):1387-98.
    View in: PubMed
  6. Hill G, Barron R, Fust K, Skornicki ME, Taylor DC, Weinstein MC, Lyman GH. Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses. J Med Econ. 2014 Jan; 17(1):32-42.
    View in: PubMed
  7. Pandya A, Gaziano TA, Weinstein MC, Cutler D. More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Aff (Millwood). 2013 Oct; 32(10):1706-14.
    View in: PubMed
  8. McGarry LJ, Krishnarajah G, Hill G, Skornicki M, Pruttivarasin N, Masseria C, Arondekar B, Pelton SI, Weinstein MC. Cost-effectiveness analysis of tdap in the prevention of pertussis in the elderly. PLoS One. 2013; 8(9):e67260.
    View in: PubMed
  9. Patrick AR, Franklin JM, Weinstein MC, Glynn RJ, Schneeweiss S. Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases: The Comparative Safety of Prasugrel v. Clopidogrel. Med Decis Making. 2013 Oct; 33(7):949-60.
    View in: PubMed
  10. Hicks CW, Weinstein M, Wakamatsu M, Pulliam S, Savitt L, Bordeianou L. Are rectoceles the cause or the result of obstructed defaecation syndrome? A prospective anorectal physiology study. Colorectal Dis. 2013 Aug; 15(8):993-9.
    View in: PubMed
  11. Parthan A, Leahy KJ, O'Sullivan AK, Iakoubova OA, Bare LA, Devlin JJ, Weinstein MC. Cost Effectiveness of Targeted High-dose Atorvastatin Therapy Following Genotype Testing in Patients with Acute Coronary Syndrome. Pharmacoeconomics. 2013 Jun; 31(6):519-31.
    View in: PubMed
  12. McGarry LJ, Gilmore KE, Rubin JL, Klugman KP, Strutton DR, Weinstein MC. Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States. BMC Infect Dis. 2013; 13:229.
    View in: PubMed
  13. Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.
    View in: PubMed
  14. Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MC. Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Eff Resour Alloc. 2012; 10(1):12.
    View in: PubMed
  15. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6. Value Health. 2012 Sep-Oct; 15(6):835-42.
    View in: PubMed
  16. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making. 2012 Sep-Oct; 32(5):722-32.
    View in: PubMed
  17. Strutton DR, Farkouh RA, Rubin JL, McGarry LJ, Loiacono PM, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data. BMC Infect Dis. 2012; 12:175.
    View in: PubMed
  18. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012 Jul; 32 Suppl 1:S117-24.
    View in: PubMed
  19. Lorenzana SB, Hughes MD, Grinsztejn B, Collier AC, Luz PM, Freedberg KA, Wood R, Levison JH, Mugyenyi PN, Salata R, Wallis CL, Weinstein MC, Schooley RT, Walensky RP. Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial. AIDS. 2012 Jun 1; 26(9):1083-93.
    View in: PubMed
  20. McGarry LJ, Pawar VS, Panchmatia HR, Rubin JL, Davis GL, Younossi ZM, Capretta JC, O'Grady MJ, Weinstein MC. Economic model of a birth cohort screening program for hepatitis C virus. Hepatology. 2012 May; 55(5):1344-55.
    View in: PubMed
  21. Taylor DC, Pawar V, Kruzikas DT, Gilmore KE, Sanon M, Weinstein MC. Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches. Pharmacoeconomics. 2012 Feb 1; 30(2):119-26.
    View in: PubMed
  22. O'Sullivan AK, Weinstein MC, Pandya A, Thompson D, Langston AA, Perfect JR, Papadopoulos G. Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease. Am J Health Syst Pharm. 2012 Jan 15; 69(2):149-56.
    View in: PubMed
  23. Hiremath S, Knoll G, Weinstein MC. Should the arteriovenous fistula be created before starting dialysis?: a decision analytic approach. PLoS One. 2011; 6(12):e28453.
    View in: PubMed
  24. Tosteson AN, Tosteson TD, Lurie JD, Abdu W, Herkowitz H, Andersson G, Albert T, Bridwell K, Zhao W, Grove MR, Weinstein MC, Weinstein JN. Comparative effectiveness evidence from the spine patient outcomes research trial: surgical versus nonoperative care for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine (Phila Pa 1976). 2011 Nov 15; 36(24):2061-8.
    View in: PubMed
  25. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011 Nov; 6(11):1841-8.
    View in: PubMed
  26. Pandya A, Weinstein MC, Gaziano TA. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population. PLoS One. 2011; 6(5):e20416.
    View in: PubMed
  27. Taylor DC, Pawar V, Kruzikas D, Gilmore KE, Pandya A, Iskandar R, Weinstein MC. Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices. Value Health. 2011 Jul-Aug; 14(5):700-4.
    View in: PubMed
  28. Ladapo JA, Jaffer FA, Weinstein MC, Froelicher ES. Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction. Arch Intern Med. 2011 Jan 10; 171(1):39-45.
    View in: PubMed
  29. Groot Koerkamp B, Stijnen T, Weinstein MC, Hunink MG. The combined analysis of uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2011 Jul-Aug; 31(4):650-61.
    View in: PubMed
  30. Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med. 2010 Oct 14; 363(16):1495-7.
    View in: PubMed
  31. Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine. 2010 Nov 10; 28(48):7634-43.
    View in: PubMed
  32. Rydzak CE, Cotich KL, Sax PE, Hsu HE, Wang B, Losina E, Freedberg KA, Weinstein MC, Goldie SJ. Assessing the performance of a computer-based policy model of HIV and AIDS. PLoS One. 2010; 5(9).
    View in: PubMed
  33. Campbell J, McGarry LA, Shikora SA, Hale BC, Lee JT, Weinstein MC. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010 Jul; 16(7):e174-87.
    View in: PubMed
  34. Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA. Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):258-68.
    View in: PubMed
  35. McGarry LJ, Merchant S, Nathwani D, Pawar V, DeLong K, Thompson D, Akhras K, Ingham M, Weinstein MC. Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia. J Med Econ. 2010 Mar; 13(1):142-7.
    View in: PubMed
  36. Groot Koerkamp B, Weinstein MC, Stijnen T, Heijenbrok-Kal MH, Hunink MG. Uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2010 Mar-Apr; 30(2):194-205.
    View in: PubMed
  37. Rubin JL, McGarry LJ, Klugman KP, Strutton DR, Gilmore KE, Weinstein MC. Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. BMC Infect Dis. 2010; 10:14.
    View in: PubMed
  38. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending--implications for reform. N Engl J Med. 2010 Feb 4; 362(5):460-5.
    View in: PubMed
  39. Rosen VM, Taylor DC, Parekh H, Pandya A, Thompson D, Kuznik A, Waters DD, Drummond M, Weinstein MC. Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US. Pharmacoeconomics. 2010; 28(1):47-60.
    View in: PubMed
  40. Taylor DC, Pawar V, Kruzikas D, Gilmore KE, Pandya A, Iskandar R, Weinstein MC. Methods of model calibration: observations from a mathematical model of cervical cancer. Pharmacoeconomics. 2010; 28(11):995-1000.
    View in: PubMed
  41. Ladapo JA, Jaffer FA, Hoffmann U, Thomson CC, Bamberg F, Dec W, Cutler DM, Weinstein MC, Gazelle GS. Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol. 2009 Dec 15; 54(25):2409-22.
    View in: PubMed
  42. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009 Nov 15; 49(10):1570-8.
    View in: PubMed
  43. Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal. PLoS Med. 2009 Oct; 6(10):e1000173.
    View in: PubMed
  44. Ladapo JA, Horwitz JR, Weinstein MC, Gazelle GS, Cutler DM. Adoption and spread of new imaging technology: a case study. Health Aff (Millwood). 2009 Nov-Dec; 28(6):w1122-32.
    View in: PubMed
  45. Ruger JP, Emmons KM, Kearney MH, Weinstein MC. Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women. BMC Pregnancy Childbirth. 2009; 9:46.
    View in: PubMed
  46. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009 Aug 4; 151(3):157-66.
    View in: PubMed
  47. Bentley TG, Weinstein MC, Kuntz KM. Effects of categorizing continuous variables in decision-analytic models. Med Decis Making. 2009 Sep-Oct; 29(5):549-56.
    View in: PubMed
  48. O'Sullivan AK, Pandya A, Papadopoulos G, Thompson D, Langston A, Perfect J, Weinstein MC. Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States. Value Health. 2009 Jul-Aug; 12(5):666-73.
    View in: PubMed
  49. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009 Jul; 27(7):1472-7.
    View in: PubMed
  50. Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009 Mar; 12 Suppl 1:S5-9.
    View in: PubMed
  51. Bentley TGK, Weinstein MC, Kuntz KM. Effects of categorizing continuous variables in decision-analytic models. Medical Decision Making. 2009; 29:549-556.
  52. O’Sullivan AK, Pandya A, Papadopoulos G, Thompson D, Langston A, Perfect J, Weinstein MC. Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States. Value in Health. 2009; 12:666-673.
  53. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RH, Paltiel AD, Freedberg KA. Racial and gender disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation and early discontinuation of antiretroviral therapy. Clinical Infectious Diseases. 2009; 49:1570-1578.
  54. O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009 Jan; 25(1):14-25.
    View in: PubMed
  55. Ladapo JA, Horwitz JR, Weinstein MC, Gazelle GS, Cutler DM. Adoption and spread of new imaging technology: a case study. Health Affairs. 2009; 28:w1122-w1132.
  56. Taylor DCA, Pandya A, Thompson D, Chu P, Graff J, Shepherd J, Wenger N, Greten H, Carmena R, Drummond M, Weinstein MC. Cost-Effectiveness of Intensive Atorvastatin Therapy in Secondary Cardiovascular Prevention in the UK, Spain, and Germany, Based on the Treating to New Targets (TNT) Study. European Journal of Health Economics. 2009; 10:255-265.
  57. Chan DC, Pollett PK, Weinstein MC. Quantitative risk stratification in Markov chains with conditional limiting distributions. Medical Decision Making. 2009; 29:532-540.
  58. McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer. 2008 Dec 15; 113(12):3440-9.
    View in: PubMed
  59. Ciaranello AL, Seage GR, Freedberg KA, Weinstein MC, Lockman S, Walensky RP. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS. 2008 Nov 12; 22(17):2359-69.
    View in: PubMed
  60. Taylor DC, Pandya A, Thompson D, Chu P, Graff J, Shepherd J, Wenger N, Greten H, Carmena R, Drummond M, Weinstein MC. Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study. Eur J Health Econ. 2009 Jul; 10(3):255-65.
    View in: PubMed
  61. Ladapo JA, Hoffmann U, Bamberg F, Nagurney JT, Cutler DM, Weinstein MC, Gazelle GS. Cost-effectiveness of coronary multidetector computer tomography in the triage of patients with acute chest pain. American Journal of Roentgenology. 2008; 191(2):455-463..
  62. Walensky RP, Freedberg KA, Weinstein MC. Monitoring of antiretroviral therapy in low-resource settings. Lancet. 2008 Jul 26; 372(9635):288; author reply 289.
    View in: PubMed
  63. Bentley TG, Weinstein MC, Willett WC, Kuntz KM. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 2009 Apr; 12(4):455-67.
    View in: PubMed
  64. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008 Jul; 248(1):278-87.
    View in: PubMed
  65. Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA, and the CEPAC-International Investigators. Scaling Up Anti-retroviral Therapy in South Africa : The Impact of Speed on Survival. Journal of Infectious Diseases. 2008; 197(9):1324-32 ..
  66. Weinstein MC. How much are Americans willing to pay for a quality-adjusted life year? Med Care. 2008 Apr; 46(4):343-5.
    View in: PubMed
  67. Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, Gazelle GS. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology. 2008 Mar; 246(3):763-71.
    View in: PubMed
  68. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008 Mar; 14(2):171-232.
    View in: PubMed
  69. Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health. 2008 Mar-Apr; 11(2):213-20.
    View in: PubMed
  70. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money?. New England Journal of Medicine. 2008; 358:661-663..
  71. Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007 Dec 15; 45 Suppl 4:S248-54.
    View in: PubMed
  72. Chan DC, Heidenreich PA, Weinstein MC, Fonarow GC. Heart failure disease management programs: a cost-effectiveness analysis. Am Heart J. 2008 Feb; 155(2):332-8.
    View in: PubMed
  73. Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KA. The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med. 2007 Oct; 8(7):439-50.
    View in: PubMed
  74. Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Value Health. 2008 Mar-Apr; 11(2):191-8.
    View in: PubMed
  75. Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA. Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis. 2007 Oct 15; 45(8):1062-70.
    View in: PubMed
  76. Thompson D, Taylor DC, Montoya EL, Winer EP, Jones SE, Weinstein MC. Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer. Value Health. 2007 Sep-Oct; 10(5):367-76.
    View in: PubMed
  77. Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS. 2007 Jul; 21 Suppl 4:S117-28.
    View in: PubMed
  78. Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA. HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS. 2007 May 11; 21(8):973-82.
    View in: PubMed
  79. Aballéa S, Chancellor JV, Raikou M, Drummond MF, Weinstein MC, Jourdan S, Bridgewater J. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer. 2007 Mar 15; 109(6):1082-9.
    View in: PubMed
  80. McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, Weinstein MC, Paltiel AD, Freedberg KA, Seage GR. The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis. 2007 Apr 15; 44(8):1115-22.
    View in: PubMed
  81. Groot Koerkamp B, Hunink MG, Stijnen T, Hammitt JK, Kuntz KM, Weinstein MC. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis. Med Decis Making. 2007 Mar-Apr; 27(2):101-11.
    View in: PubMed
  82. Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, Toniolo-Neto J, Drummond M, Weinstein M. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health. 2007 Mar-Apr; 10(2):98-116.
    View in: PubMed
  83. Thompson D, Taylor DCA, Montoya EL, Winer EP, Jones SE, Weinstein MC. Cost-Effectiveness of Switching to Exemestane Following Two-to-Three Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer. Value in Health. 2007; 10:367-376..
  84. Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA. Potential risks and benefits of HIV regimen simplification: a simulation model of a proposed clinical trial. Clinical Infectious Diseases. 2007; 45:1062-1070..
  85. Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-Effectiveness of HIV Testing and Treatment in the United States. Clinical Infectious Diseases. 2007; 45(Suppl 4):S248-S254..
  86. Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, Weinstein MC, Freedberg KA. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006 Dec 5; 145(11):797-806.
    View in: PubMed
  87. Freedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, Losina E. Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Dec 1; 43 Suppl 1:S113-8.
    View in: PubMed
  88. Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health services when resources are limited: the example of a cervical cancer screening visit. PLoS Med. 2006 Nov; 3(11):e434.
    View in: PubMed
  89. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR, Moore RD, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006 Nov; 44(11):990-7.
    View in: PubMed
  90. Bentley TG, Willett WC, Weinstein MC, Kuntz KM. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health. 2006 Nov; 96(11):2040-7.
    View in: PubMed
  91. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med. 2006 Sep 14; 355(11):1141-53.
    View in: PubMed
  92. McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making. 2006 Sep-Oct; 26(5):497-511.
    View in: PubMed
  93. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006 Aug 19; 368(9536):679-86.
    View in: PubMed
  94. Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med. 2006 Jul; 3(7):e241.
    View in: PubMed
  95. Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KA. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J. 2006 Jun; 96(6):526-9.
    View in: PubMed
  96. Kim SY, Billah K, Lieu TA, Weinstein MC. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Am J Prev Med. 2006 Jun; 30(6):498-506.
    View in: PubMed
  97. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006 Jul 1; 194(1):11-9.
    View in: PubMed
  98. Groot Koerkamp B, Myriam Hunink MG, Stijnen T, Weinstein MC. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods. Health Econ. 2006 Apr; 15(4):383-92.
    View in: PubMed
  99. Zupancic JA, Richardson DK, O'Brien BJ, Cronin CG, Schmidt B, Roberts R, Weinstein MC. Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. Early Hum Dev. 2006 Feb; 82(2):97-103.
    View in: PubMed
  100. Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics. 2006; 24(11):1043-53.
    View in: PubMed
  101. Aballéa S, Martin M, Chancellor J, Carrat F, Drummond M, Weinstein M. Analyse coût-efficacité de la vaccination contre la grippe chez les personnes de 50 à 64 ans en France. Journal d'Économie Médicale. 2006; 24(6):267-285..
  102. Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB. Do drug formulary policies reflect evidence of value? Am J Manag Care. 2006 Jan; 12(1):30-6.
    View in: PubMed
  103. Weinstein MC. Decision rules for incremental cost-effectiveness analysis. In (Jones AM, Ed.) The Elgar Companion to Health Economics. 2006.
  104. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005 Dec 6; 112(23):3569-76.
    View in: PubMed
  105. Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med. 2005 Oct 6; 353(14):1516-22.
    View in: PubMed
  106. Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005 Nov 1; 41(9):1316-23.
    View in: PubMed
  107. Elkin EB, Weinstein MC, Kuntz KM, Bunnell CA, Weeks JC. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs. Breast Cancer Res Treat. 2005 Sep; 93(1):25-34.
    View in: PubMed
  108. Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS. 2005 Aug 12; 19(12):1299-308.
    View in: PubMed
  109. Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005 Jul 19; 143(2):89-99.
    View in: PubMed
  110. Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC. Can we better prioritize resources for cost-utility research? Med Decis Making. 2005 Jul-Aug; 25(4):429-36.
    View in: PubMed
  111. Aledort JE, Hook EW, Weinstein MC, Goldie SJ. The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis. 2005 Jul; 32(7):425-36.
    View in: PubMed
  112. Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine. 2005 May 2; 23(24):3187-95.
    View in: PubMed
  113. Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. J Acquir Immune Defic Syndr. 2005 May 1; 39(1):69-77.
    View in: PubMed
  114. Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making. 2005 May-Jun; 25(3):321-9.
    View in: PubMed
  115. Walensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel AD. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005 Mar; 118(3):292-300.
    View in: PubMed
  116. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med. 2005 Feb 10; 352(6):586-95.
    View in: PubMed
  117. Rinfret S, Cohen DJ, Lamas GA, Fleischmann KE, Weinstein MC, Orav J, Schron E, Lee KL, Goldman L. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Circulation. 2005 Jan 18; 111(2):165-72.
    View in: PubMed
  118. Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antivir Ther. 2005; 10(1):41-52.
    View in: PubMed
  119. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: asking the right questions, choosing the right method. Health Aff (Millwood). 2005 Jan-Feb; 24(1):128-32.
    View in: PubMed
  120. Neumann, Peter J; Rosen, Allison B; Greenberg, Dan; Olchanski, Natalia V; Pande, Richa; Chapman, Richard H; Stone, Patricia W; Ondategui-Parra, Silvia; Nadai, John; Siegel, Joanna E; Weinstein, Milton C. Can We Better Prioritize Resources for Cost-Utility Research?. Medical Decision Making. 2005; 25:429-436.
  121. Weinstein, Milton C. Spending health care dollars wisely: can cost-effectiveness analysis help?. Sixteenth Annual Herbert Lourie Memorial Lecture on Health Policy. Policy Brief No. 30. 2005.
  122. Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Medical Decision Making. 2005; 25:321-329.
  123. Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA. Should Resistance Testing be Performed in Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis. Clinical Infectious Diseases. 2005; 41:1316-1323.
  124. Weinstein, Milton C. Quality-adjusted life years: application to food safety priority setting. (Hoffman SA, Taylor MR, Eds.) Toward Safer Food: Perspectives on Risk and Priority Setting. 2005.
  125. Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz K. Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment. Health Care Financ Rev. 2005; 26(4):67-80.
    View in: PubMed
  126. Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology. 2004 Dec; 233(3):729-39.
    View in: PubMed
  127. Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KA. A therapeutic HIV vaccine: how good is good enough? Vaccine. 2004 Sep 28; 22(29-30):4044-53.
    View in: PubMed
  128. Salomon JA, Weinstein MC, Goldie SJ. Taking account of future technology in cost effectiveness analysis. BMJ. 2004 Sep 25; 329(7468):733-6.
    View in: PubMed
  129. McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care. 2004 Sep; 10(9):632-42.
    View in: PubMed
  130. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis. Value Health. 2004 Sep-Oct; 7(5):554-68.
    View in: PubMed
  131. Elstein AS, Fryback DG, Weinstein MC, Pauker SG, Holmes-Rovner M, Young MJ, Barry MJ, Eckman MH, Hunink MG, Tsevat J, Wong JB. Presidential reflections on the 25th anniversary of the society for medical decision making. Med Decis Making. 2004 Jul-Aug; 24(4):408-20.
    View in: PubMed
  132. Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ. When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004 May; 13(5):429-36.
    View in: PubMed
  133. Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004 Apr 21; 96(8):604-15.
    View in: PubMed
  134. Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2004 Mar 1; 22(5):854-63.
    View in: PubMed
  135. Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ. Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol. 2004 Feb 15; 93(4):509-11.
    View in: PubMed
  136. Neumann PJ, Weinstein MC. Rational rationing: There is a way to get the most health care bang for the buck. Commonwealth. 2004; 9(3):9-10.
  137. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang. 2004 Jan; 86(1):28-40.
    View in: PubMed
  138. Weinstein, MC. Rigorous modeling of risk, clinical benefit and cost. The Sir Stanley Davidson Lecture. Journal of the Royal College of Physicians Edinburgh. 2004; 34:58-60.
  139. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003 Dec 1; 115(8):632-41.
    View in: PubMed
  140. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003 Oct 10; 106(6):896-904.
    View in: PubMed
  141. Weinstein MC. Coronary artery bypass surgery is still cost-effective: using calibrated models to update clinical trials. Am J Med. 2003 Oct 1; 115(5):410-1.
    View in: PubMed
  142. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA. 2003 Jul 9; 290(2):228-37.
    View in: PubMed
  143. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Patient and community preferences for treatments and health states in multiple sclerosis. Mult Scler. 2003 Jun; 9(3):311-9.
    View in: PubMed
  144. Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg. 2003 Apr; 237(4):544-55.
    View in: PubMed
  145. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein MC, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV 16/18 vaccine. International Journal of Cancer. 2003; 106:896-904.
  146. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. Value Health. 2003 Jan-Feb; 6(1):9-17.
    View in: PubMed
  147. Zupancic JA, Richardson DK, O'Brien BJ, Schmidt B, Weinstein MC. Daily cost prediction model in neonatal intensive care. Int J Technol Assess Health Care. 2003; 19(2):330-8.
    View in: PubMed
  148. Zupancic JA, Richardson DK, O'Brien BJ, Eichenwald EC, Weinstein MC. Cost-effectiveness analysis of predischarge monitoring for apnea of prematurity. Pediatrics. 2003 Jan; 111(1):146-52.
    View in: PubMed
  149. Yazdanpanah Y, Goldie SJ, Paltiel AD, Losina E, Coudeville L, Weinstein MC, Gerard Y, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis. 2003 Jan 1; 36(1):86-96.
    View in: PubMed
  150. Lieu TA, Thompson KM, Prosser LA, O'Brien MA, Yusuf HR, Shefer AM, Weinstein MC, Rickert DL. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines. 2002 Dec; 1(4):433-42.
    View in: PubMed
  151. Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Antivir Ther. 2002 Dec; 7(4):257-66.
    View in: PubMed
  152. McGarry LJ, Thompson D, Millham FH, Cowell L, Snyder PJ, Lenderking WR, Weinstein MC. Outcomes and costs of acute treatment of traumatic brain injury. J Trauma. 2002 Dec; 53(6):1152-9.
    View in: PubMed
  153. Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med. 2002 Nov 25; 162(21):2478-86.
    View in: PubMed
  154. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis. Med Decis Making. 2002 Nov-Dec; 22(6):506-13.
    View in: PubMed
  155. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol. 2002 Oct 15; 156(8):761-73.
    View in: PubMed
  156. Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):27-37.
    View in: PubMed
  157. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
  158. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002 Jul 24-31; 288(4):455-61.
    View in: PubMed
  159. Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. Arch Intern Med. 2002 Apr 22; 162(8):921-8.
    View in: PubMed
  160. Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol. 2002 Apr 1; 20(7):1786-92.
    View in: PubMed
  161. Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MC. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making. 2002 Jan-Feb; 22(1):27-38.
    View in: PubMed
  162. Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK. Modeling for health care and other policy decisions: uses, roles, and validity. Value Health. 2001 Sep-Oct; 4(5):348-61.
    View in: PubMed
  163. Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA. Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health. 2001 Sep; 91(9):1456-63.
    View in: PubMed
  164. Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, Goldman PA, Williams L, Goldman L. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA. 2001 Aug 22-29; 286(8):936-43.
    View in: PubMed
  165. Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KM. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med. 2001 Aug; 111(2):140-9.
    View in: PubMed
  166. Tsevat J, Kuntz KM, Orav EJ, Weinstein MC, Sacks FM, Goldman L. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J. 2001 May; 141(5):727-34.
    View in: PubMed
  167. Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KA. Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med. 2001 Mar 20; 134(6):440-50.
    View in: PubMed
  168. Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001 Mar 15; 344(11):824-31.
    View in: PubMed
  169. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol. 2001 Feb 15; 19(4):1064-70.
    View in: PubMed
  170. Hunink M, Glasziou P, Siegel J, Weeks J, Pliskin J, Elstein A, Weinstein M. Decision Making in Health and Medicine: Integrating Evidence and Values. 2001.
  171. Claxton K, Neumann PJ, Araki S, Weinstein MC. Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care. 2001; 17(1):38-55.
    View in: PubMed
  172. Kuntz K, Weinstein M. Modelling in economic evaluation. Economic Evaluation in Health Care: Merging Theory with Practice. (Drummond M, McGuire A, Eds.). 2001.
  173. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA. 2000 Dec 6; 284(21):2748-54.
    View in: PubMed
  174. Mrus JM, Goldie SJ, Weinstein MC, Tsevat J. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS. 2000 Nov 10; 14(16):2543-52.
    View in: PubMed
  175. Neumann PJ, Claxton K, Weinstein MC. The FDA's regulation of health economic information. Health Aff (Millwood). 2000 Sep-Oct; 19(5):129-37.
    View in: PubMed
  176. Halpern EF, Weinstein MC, Hunink MG, Gazelle GS. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making. 2000 Jul-Sep; 20(3):314-22.
    View in: PubMed
  177. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000 Jun 1; 108(8):634-41.
    View in: PubMed
  178. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000 May 16; 132(10):769-79.
    View in: PubMed
  179. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, Weeks JC. Who gets chemotherapy for metastatic lung cancer? Chest. 2000 May; 117(5):1239-46.
    View in: PubMed
  180. Prosser LA, Koplan JP, Neumann PJ, Weinstein MC. Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care. 2000 Feb; 6(2):173-9.
    View in: PubMed
  181. Beckett M, Weinstein M, Goldman N, Yu-Hsuan L. Do health interview surveys yield reliable data on chronic illness among older respondents? Am J Epidemiol. 2000 Feb 1; 151(3):315-23.
    View in: PubMed
  182. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000; 21:587-611.
    View in: PubMed
  183. Kuntz KM, Tsevat J, Weinstein MC, Goldman L. Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction. JAMA. 1999 Dec 15; 282(23):2246-51.
    View in: PubMed
  184. Weinstein MC. Theoretically correct cost-effectiveness analysis. Med Decis Making. 1999 Oct-Dec; 19(4):381-2; discussion 383-4.
    View in: PubMed
  185. Goldman L, Coxson P, Hunink MG, Goldman PA, Tosteson AN, Mittleman M, Williams L, Weinstein MC. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol. 1999 Sep; 34(3):768-76.
    View in: PubMed
  186. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999 May 19; 281(19):1822-9.
    View in: PubMed
  187. Weinstein MC. High-priced technology can be good value for money. Ann Intern Med. 1999 May 18; 130(10):857-8.
    View in: PubMed
  188. Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, Berenbaum PA, Goldman PA, Williams LW, Weinstein MC. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology. 1999 Apr 12; 52(6):1138-45.
    View in: PubMed
  189. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med. 1999 Jan 19; 130(2):97-107.
    View in: PubMed
  190. Neumann PJ, Kuntz KM, Leon J, Araki SS, Hermann RC, Hsu MA, Weinstein MC. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care. 1999 Jan; 37(1):27-32.
    View in: PubMed
  191. Redelmeier DA, Weinstein MC. Cost-effectiveness of regulations against using a cellular telephone while driving. Med Decis Making. 1999 Jan-Mar; 19(1):1-8.
    View in: PubMed
  192. Scharfstein JA, Paltiel AD, Weinstein MC, Seage GR, Losina E, Craven DE, Freedberg KA. The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. Int J Technol Assess Health Care. 1999; 15(3):531-47.
    View in: PubMed
  193. Bosch JL, Hammitt JK, Weinstein MC, Hunink MG. Estimating general-population utilities using one binary-gamble question per respondent. Med Decis Making. 1998 Oct-Dec; 18(4):381-90.
    View in: PubMed
  194. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions--standardizing data on outcomes. N Engl J Med. 1998 Aug 6; 339(6):380-6.
    View in: PubMed
  195. Lee SJ, Liljas B, Neumann PJ, Weinstein MC, Johannesson M. The impact of risk information on patients' willingness to pay for autologous blood donation. Med Care. 1998 Aug; 36(8):1162-73.
    View in: PubMed
  196. Hunink MG, Bult JR, de Vries J, Weinstein MC. Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making. 1998 Jul-Sep; 18(3):337-46.
    View in: PubMed
  197. Bult JR, Hunink MG, Tsevat J, Weinstein MC. Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients. Med Care. 1998 Apr; 36(4):523-32.
    View in: PubMed
  198. Gray DT, Weinstein MC. Decision and cost-utility analyses of surgical versus transcatheter closure of patent ductus arteriosus: should you let a smile be your umbrella? Med Decis Making. 1998 Apr-Jun; 18(2):187-201.
    View in: PubMed
  199. Paltiel AD, Scharfstein JA, Seage GR, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making. 1998 Apr-Jun; 18(2 Suppl):S93-105.
    View in: PubMed
  200. Tu JV, Weinstein MC, McNeil BJ, Naylor CD. Predicting mortality after coronary artery bypass surgery: what do artificial neural networks learn? The Steering Committee of the Cardiac Care Network of Ontario. Med Decis Making. 1998 Apr-Jun; 18(2):229-35.
    View in: PubMed
  201. Freedberg KA, Scharfstein JA, Seage GR, Losina E, Weinstein MC, Craven DE, Paltiel AD. The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA. 1998 Jan 14; 279(2):130-6.
    View in: PubMed
  202. Neumann PJ, Hermann RC, Weinstein MC. Measuring QALYs in dementia. Health Economics of Dementia. (Wimo A, Jönsson B, Karlsson G, Winblad B, Eds.). 1998.
  203. Weinstein M. Milton Weinstein's insights on the development, use, and methodologic problems in cost-effectiveness analysis. Image J Nurs Sch. 1998; 30(3):223-7.
    View in: PubMed
  204. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health. 1998; 19:125-52.
    View in: PubMed
  205. Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann Intern Med. 1997 Dec 15; 127(12):1080-8.
    View in: PubMed
  206. Lieu TA, Gurley RJ, Lundstrom RJ, Ray GT, Fireman BH, Weinstein MC, Parmley WW. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1997 Dec; 30(7):1741-50.
    View in: PubMed
  207. Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. The cost-effectiveness of air bags by seating position. JAMA. 1997 Nov 5; 278(17):1418-25.
    View in: PubMed
  208. Neumann PJ, Hermann RC, Berenbaum PA, Weinstein MC. Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease. Psychiatr Serv. 1997 Nov; 48(11):1440-4.
    View in: PubMed
  209. Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC. Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis Making. 1997 Oct-Dec; 17(4):455-63.
    View in: PubMed
  210. Mandelblatt JS, Fryback DG, Weinstein MC, Russell LB, Gold MR. Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine. J Gen Intern Med. 1997 Sep; 12(9):551-8.
    View in: PubMed
  211. Weinstein MC, Siegel JE, Garber AM, Lipscomb J, Luce BR, Manning WG, Torrance GW. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ. 1997 Sep-Oct; 6(5):505-10.
    View in: PubMed
  212. Lee SJ, Neumann PJ, Churchill WH, Cannon ME, Weinstein MC, Johannesson M. Patients' willingness to pay for autologous blood donation. Health Policy. 1997 Apr; 40(1):1-12.
    View in: PubMed
  213. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997 Feb 19; 277(7):535-42.
    View in: PubMed
  214. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics. 1997 Feb; 11(2):159-68.
    View in: PubMed
  215. Weinstein MC, Manning WG. Theoretical issues in cost-effectiveness analysis. J Health Econ. 1997 Feb; 16(1):121-8.
    View in: PubMed
  216. Tosteson AN, Weinstein MC, Hunink MG, Mittleman MA, Williams LW, Goldman PA, Goldman L. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation. 1997 Jan 7; 95(1):24-30.
    View in: PubMed
  217. Jönsson B, Weinstein MC. Economic evaluation alongside multinational clinical trials. Study considerations for GUSTO IIb. Int J Technol Assess Health Care. 1997; 13(1):49-58.
    View in: PubMed
  218. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16; 276(15):1253-8.
    View in: PubMed
  219. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 9; 276(14):1172-7.
    View in: PubMed
  220. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 23-30; 276(16):1339-41.
    View in: PubMed
  221. Kuntz KM, Tsevat J, Goldman L, Weinstein MC. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation. 1996 Sep 1; 94(5):957-65.
    View in: PubMed
  222. Coley CM, Li YH, Medsger AR, Marrie TJ, Fine MJ, Kapoor WN, Lave JR, Detsky AS, Weinstein MC, Singer DE. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med. 1996 Jul 22; 156(14):1565-71.
    View in: PubMed
  223. Tengs TO, Meyer G, Siegel JE, Pliskin JS, Graham JD, Weinstein MC. Oregon's Medicaid ranking and cost-effectiveness: is there any relationship? Med Decis Making. 1996 Apr-Jun; 16(2):99-107.
    View in: PubMed
  224. Weinstein MC. Spine update. Spine (Phila Pa 1976). 1996 Mar 1; 21(5):651-2.
    View in: PubMed
  225. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Journal of the American Medical Association. 1996; 276:1172-1177..
  226. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds.). Cost-Effectiveness in Health and Medicine: Report of the Panel on Cost-Effectiveness in Health and Medicine. 1996.
  227. Weinstein MC, Pliskin JS. Healthy Years Equivalents: what are the issues?. Medical Decision Making. 1996; 16:205-206.
  228. Villari P, Fattore G, Siegel JE, Paltiel AD, Weinstein MC. Economic evaluation of HIV testing among intravenous drug users. An analytic framework and its application to Italy. Int J Technol Assess Health Care. 1996; 12(2):336-57.
    View in: PubMed
  229. Tsevat J, Solzan JG, Kuntz KM, Ragland J, Currier JS, Sell RL, Weinstein MC. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. Med Care. 1996 Jan; 34(1):44-57.
    View in: PubMed
  230. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995 Jun; 15(3):369-90.
    View in: PubMed
  231. Kuntz KM, Weinstein MC. Life expectancy biases in clinical decision modeling. Med Decis Making. 1995 Apr-Jun; 15(2):158-69.
    View in: PubMed
  232. Cohen DJ, Goldman L, Weinstein MC. The cost-effectiveness of programs to lower serum cholesterol. Lowering Cholesterol in High-Risk Individuals and Populations. (Rifkind BM, Ed.). 1995.
  233. Weinstein MC. Allocation of subjects in medical experiments. 1974. MD Comput. 1995 Jan-Feb; 12(1):36-44.
    View in: PubMed
  234. Johannesson M, Weinstein MC. Designing and conducting cost-benefit analyses. Quality of Life and Pharmacoeconomics in Clinical Trials. (Spilker B, Ed.). 1995.
  235. Weinstein MC. From cost-effectiveness ratios to resource allocation: where to draw the line?. Valuing Health Care. (Sloan FA, Ed.). 1995.
  236. Revicki DA, Allen H, Bungay K, Williams GH, Weinstein MC. Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertension. J Clin Epidemiol. 1994 Dec; 47(12):1333-42.
    View in: PubMed
  237. Tosteson AN, Weinstein MC, Wittenberg J, Begg CB. ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment. Environ Health Perspect. 1994 Nov; 102 Suppl 8:73-8.
    View in: PubMed
  238. Gaspoz JM, Lee TH, Weinstein MC, Cook EF, Goldman P, Komaroff AL, Goldman L. Cost-effectiveness of a new short-stay unit to "rule out" acute myocardial infarction in low risk patients. J Am Coll Cardiol. 1994 Nov 1; 24(5):1249-59.
    View in: PubMed
  239. Tsevat J, Weeks JC, Guadagnoli E, Tosteson AN, Mangione CM, Pliskin JS, Weinstein MC, Cleary PD. Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med. 1994 Oct; 9(10):576-82.
    View in: PubMed
  240. Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N Engl J Med. 1994 Jul 28; 331(4):239-43.
    View in: PubMed
  241. Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 1994 May 23; 154(10):1143-9.
    View in: PubMed
  242. Cohen DJ, Breall JA, Ho KK, Kuntz RE, Goldman L, Baim DS, Weinstein MC. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation. 1994 Apr; 89(4):1859-74.
    View in: PubMed
  243. Johannesson M, Pliskin JS, Weinstein MC. A note on QALYs, time tradeoff, and discounting. Med Decis Making. 1994 Apr-Jun; 14(2):188-93.
    View in: PubMed
  244. Redelmeier DA, Heller DN, Weinstein MC. Time preference in medical economics: science or religion?. Medical Decision Making. 1994; 14:301-303.
  245. Tosteson ANA, Weinstein MC, Schiff I. Cost-effectiveness analysis of hormone replacement therapy. Treatment of the Postmenopausal Woman. (Lobo RA, Ed.). 1994.
  246. Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ. 1993 Dec; 12(4):459-67.
    View in: PubMed
  247. Gray DT, Fyler DC, Walker AM, Weinstein MC, Chalmers TC. Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med. 1993 Nov 18; 329(21):1517-23.
    View in: PubMed
  248. Krumholz HM, Cohen BJ, Tsevat J, Pasternak RC, Weinstein MC. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol. 1993 Nov 15; 22(6):1697-702.
    View in: PubMed
  249. Cohen DJ, Breall JA, Ho KK, Weintraub RM, Kuntz RE, Weinstein MC, Baim DS. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol. 1993 Oct; 22(4):1052-9.
    View in: PubMed
  250. Johannesson M, Pliskin JS, Weinstein MC. Are healthy-years equivalents an improvement over quality-adjusted life years? Med Decis Making. 1993 Oct-Dec; 13(4):281-6.
    View in: PubMed
  251. Goldman L, Goldman PA, Williams LW, Weinstein MC. Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications. Am J Cardiol. 1993 Sep 30; 72(10):75D-79D.
    View in: PubMed
  252. Weinstein MC. Time-preference studies in the health care context. Med Decis Making. 1993 Jul-Sep; 13(3):218-9.
    View in: PubMed
  253. Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1992 Oct; 3(4 Suppl):S111-9.
    View in: PubMed
  254. Goldman L, Weinstein MC. Reply to Kaplan: Coronary Heart Disease Policy Model. Am J Hypertens. 1992 Sep; 5(9):666-9.
    View in: PubMed
  255. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson AN, Goldman L. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med. 1992 Jul 2; 327(1):7-13.
    View in: PubMed
  256. Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DW, Kinosian B, Weinstein MC. Cost and health implications of cholesterol lowering. Circulation. 1992 May; 85(5):1960-8.
    View in: PubMed
  257. Capilouto EI, Weinstein MC, Hemenway D, Cotton D. What is the dentist's occupational risk of becoming infected with hepatitis B or the human immunodeficiency virus? Am J Public Health. 1992 Apr; 82(4):587-9.
    View in: PubMed
  258. Kent DL, Weinstein MC. Clinical decision analysis. Clinical Efficacy and Outcome in the Diagnosis and Treatment of Low Back Pain. (Weinstein JN, Ed.). 1992.
  259. Tosteson ANA, Rosenthal DI, Melton LJ III, Weinstein MC. Cost-effectiveness of screening for osteoporosis: A decision approach for hormone replacement. Fifth International Conference on System Science in Health Care. (Chytil MK, Duni G, v.Eimeren W, Flagle ChD, Eds.). 1992.
  260. Tosteson AN, Weinstein MC. Cost-effectiveness of hormone replacement therapy after the menopause. Baillieres Clin Obstet Gynaecol. 1991 Dec; 5(4):943-59.
    View in: PubMed
  261. Siegel JE, Weinstein MC, Fineberg HV. Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence. Am J Public Health. 1991 Oct; 81(10):1273-9.
    View in: PubMed
  262. Politser PE, Berwick DM, Murphy JM, Goldman PA, Weinstein MC. Uncovering psychiatric test information with graphical techniques of Exploratory Data Analysis. Psychiatry Res. 1991 Oct; 39(1):65-79.
    View in: PubMed
  263. Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med. 1991 Jul 11; 325(2):81-6.
    View in: PubMed
  264. Tsevat J, Weinstein MC, Williams LW, Tosteson AN, Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991 Apr; 83(4):1194-201.
    View in: PubMed
  265. Weinstein MC. The cost-effectiveness of orphan drugs. Am J Public Health. 1991 Apr; 81(4):414-5.
    View in: PubMed
  266. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991 Mar 6; 265(9):1145-51.
    View in: PubMed
  267. Berwick DM, Murphy JM, Goldman PA, Ware JE, Barsky AJ, Weinstein MC. Performance of a five-item mental health screening test. Med Care. 1991 Feb; 29(2):169-76.
    View in: PubMed
  268. Tosteson ANA, Weinstein MC. Cost-effectiveness of hormone replacement therapy in the menopause. Hormone Replacement and Its Impact on Osteoporosis. Clinical Obstetrics and Gynecology (Christiansen C, Ed.). 1991.
  269. Hatziandreu EJ, Hatzakis A, Hatziyannis S, Kane MA, Weinstein MC. Cost-effectiveness of hepatitis-B vaccine in Greece. A country of intermediate HBV endemicity. Int J Technol Assess Health Care. 1991; 7(3):256-62.
    View in: PubMed
  270. Neumann PJ, Weinstein MC. Diffusion of new technology: costs and benefits to health care. Medical Innovation at the Crossroads. Volume II. Public Policy and the Economics of Medical Innovation. (Gelijns A, Halm E, Eds.). 1991.
  271. Tosteson AN, Weinstein MC, Williams LW, Goldman L. Long-term impact of smoking cessation on the incidence of coronary heart disease. Am J Public Health. 1990 Dec; 80(12):1481-6.
    View in: PubMed
  272. Capilouto E, Weinstein MC, Orav EJ, Hemenway D. Modeling dental health care workers' risk of occupational infection from bloodborne pathogens. J Dent Educ. 1990 Nov; 54(11):687-8.
    View in: PubMed
  273. Tosteson AN, Rosenthal DI, Melton LJ, Weinstein MC. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med. 1990 Oct 15; 113(8):594-603.
    View in: PubMed
  274. Weinstein MC. The costs of prevention. J Gen Intern Med. 1990 Sep-Oct; 5(5 Suppl):S89-92.
    View in: PubMed
  275. Anderson GM, Spitzer WO, Weinstein MC, Wang E, Blackburn JL, Bergman U. Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options. Clin Pharmacol Ther. 1990 Aug; 48(2):111-9.
    View in: PubMed
  276. Weinstein MC, Coley CM, Richter JM. Medical management of gallstones: a cost-effectiveness analysis. J Gen Intern Med. 1990 Jul-Aug; 5(4):277-84.
    View in: PubMed
  277. Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990 Jan 19; 263(3):407-13.
    View in: PubMed
  278. Hatziandreu EE, Carlson K, Mulley AG, Weinstein MC. Cost-effectiveness study of the extracorporeal shock-wave lithotriptor. Int J Technol Assess Health Care. 1990; 6(4):623-32.
    View in: PubMed
  279. Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care. 1990; 6(1):93-103.
    View in: PubMed
  280. Weinstein MC, Tosteson AN. Cost-effectiveness of hormone replacement. Ann N Y Acad Sci. 1990; 592:162-72; discussion 185-92.
    View in: PubMed
  281. White BA, Antczak-Bouckoms AA, Weinstein MC. Issues in the economic evaluation of community water fluoridation. J Dent Educ. 1989 Nov; 53(11):646-57.
    View in: PubMed
  282. Weinstein MC. Methodologic issues in policy modeling for cardiovascular disease. J Am Coll Cardiol. 1989 Sep; 14(3 Suppl A):38A-43A.
    View in: PubMed
  283. Goldman L, Weinstein MC, Williams LW. Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model. Circulation. 1989 Aug; 80(2):254-60.
    View in: PubMed
  284. Weinstein MC, Berwick DM, Goldman PA, Murphy JM, Barsky AJ. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care. 1989 Jun; 27(6):593-607.
    View in: PubMed
  285. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: concepts, complications, and illustrations. AIDS: Sexual Behavior and Intravenous Drug Use. (Turner CF, Miller HG, Moses LE, Eds.). 1989.
  286. Hatziandreu EI, Koplan JP, Weinstein MC, Caspersen CJ, Warner KE. A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health. 1988 Nov; 78(11):1417-21.
    View in: PubMed
  287. Lee TH, Fukui T, Weinstein MC, Tosteson AN, Goldman L. Cost-effectiveness of screening strategies for left main coronary artery disease in patients with stable angina. Med Decis Making. 1988 Oct-Dec; 8(4):268-78.
    View in: PubMed
  288. Weinstein MC. A QALY is a QALY--or is it? J Health Econ. 1988 Sep; 7(3):289-90.
    View in: PubMed
  289. Mota HC, Vijayakumar S, Sibata C, Higgins PD, Thomas FJ, Saxton J, Weinstein M. Posterior spinal cord block: a dosimetric study. Radiology. 1988 Sep; 168(3):859-61.
    View in: PubMed
  290. Goldman L, Sia ST, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med. 1988 Jul 21; 319(3):152-7.
    View in: PubMed
  291. Weinstein MC. Economic techniques for technology assessment. The Economics of Medical Technology. (Rutten FFH, Reiser SJ, Eds.). 1988.
  292. Antczak-Bouckoms AA, Weinstein MC. Cost-effectiveness analysis of periodontal disease control. J Dent Res. 1987 Nov; 66(11):1630-5.
    View in: PubMed
  293. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987 Nov; 77(11):1417-26.
    View in: PubMed
  294. Kresel JJ, Hutchings HC, MacKay DN, Weinstein MC, Read JL, Taylor-Halvorsen K, Ashley H. Application of decision analysis to drug selection for formulary addition. Hosp Formul. 1987 Jul; 22(7):658-63, 673, 676.
    View in: PubMed
  295. Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry. 1987 Jun; 44(6):550-5.
    View in: PubMed
  296. Weinstein MC. Closing remarks on the Conference on Applications of Quantitative Analytic Methods in Mental Health. Medical Care. 1987; 25:S160-S163.
  297. Weinstein MC, Read JL, MacKay DN, Kresel JJ, Ashley H, Halvorsen KT, Hutchings HC. Cost-effective choice of antimicrobial therapy for serious infections. J Gen Intern Med. 1986 Nov-Dec; 1(6):351-63.
    View in: PubMed
  298. Weinstein MC. Challenges for cost-effectiveness research. Med Decis Making. 1986 Oct-Dec; 6(4):194-8.
    View in: PubMed
  299. Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol. 1986 May; 122(5):537-45.
    View in: PubMed
  300. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term "cost effective" in medicine. N Engl J Med. 1986 Jan 23; 314(4):253-6.
    View in: PubMed
  301. Weinstein, MC. Risky choices in medical decision making: a survey. Geneva Papers on Risk and Insurance. 1986; 11:197-216.
  302. Sandberg SI, Barnes BA, Weinstein MC, Braun P. Elective hysterectomy. Benefits, risks, and costs. Med Care. 1985 Sep; 23(9):1067-85.
    View in: PubMed
  303. Berwick DM, Weinstein MC. What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care. 1985 Jul; 23(7):881-93.
    View in: PubMed
  304. Hiatt HH, Weinstein MC. Will disease prevention spare the medical commons? Ciba Found Symp. 1985; 110:218-35.
    View in: PubMed
  305. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985; 5(2):157-77.
    View in: PubMed
  306. Doubilet P, McNeil BJ, Weinstein MC. The decision concerning coronary angiography in patients with chest pain. A cost-effectiveness analysis. Med Decis Making. 1985; 5(3):293-309.
    View in: PubMed
  307. Weinstein MC. Methodologic considerations in planning clinical trials of cost-effectiveness of magnetic resonance imaging ... with a commentary on Guyatt and Drummond. Int J Technol Assess Health Care. 1985; 1(3):567-81.
    View in: PubMed
  308. Hiatt HH, Weinstein MC. Will disease prevention spare the medical commons?. The Value of Preventive Medicine. (Ciba Foundation Symposium 110). 1985.
  309. Weinstein MC, Stason WB. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health. 1985; 6:41-63.
    View in: PubMed
  310. Dichter CR, Weinstein MC. Cost-effectiveness of lowering the aflatoxin tolerance level. Food Chem Toxicol. 1984 Jun; 22(6):439-45.
    View in: PubMed
  311. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making. 1984; 4(3):315-29.
    View in: PubMed
  312. Mosteller F, Weinstein MC. Toward evaluating the cost-effectiveness of medical and social experiments. Social Experimentation. (Hausman JA, Wise DA, Eds.). 1984.
  313. Weinstein MC, Schiff I. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surv. 1983 Aug; 38(8):445-55.
    View in: PubMed
  314. Weinstein MC. Cost-effective priorities for cancer prevention. Science. 1983 Jul 1; 221(4605):17-23.
    View in: PubMed
  315. Weinstein MC, Quinn RJ. Psychological considerations in valuing health risk reductions. Natural Resources Journal. 1983; 23:659-673.
  316. Doubilet P, McNeil BJ, Weinstein MC. Optimal strategies for the diagnosis and treatment of coronary artery disease. Analysis using microcomputer. Med Decis Making. 1983; 3(1):23-8.
    View in: PubMed
  317. Weinstein MC. Economic impact and cost-effectiveness of medical technology. The Technology Explosion in Medical Science; Implications for the Health Care Industry and Public (1981-2001). (Gay JR, Sax Jacobs BJ, Eds.). 1983.
  318. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation. 1982 Nov; 66(5 Pt 2):III56-66.
    View in: PubMed
  319. Weinstein MC. Cost-effectiveness analysis in medicine: technologies for heart disease. Australian Medical Association Gazette. 1982; 274:25-30.
  320. Weinstein MC. Issues in risk assessment and analysis for the chlorofluorocarbon problem. The American Statistician. 1982; 2:317-320.
  321. Weinstein MC. A cost-effectiveness approach to decision making. Choices in Health Care (Deber RB, Thompson GG, Eds.). 1982.
  322. Berwick DM, Fineberg HV, Weinstein MC. When doctors meet numbers. Am J Med. 1981 Dec; 71(6):991-8.
    View in: PubMed
  323. Pliskin JS, Stason WB, Weinstein MC, Johnson RA, Cohn PF, McEnany MT, Braun P. Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysis. Med Decis Making. 1981; 1(1):10-28.
    View in: PubMed
  324. Weinstein MC. Economic assessments of medical practices and technologies. Med Decis Making. 1981; 1(4):309-30.
    View in: PubMed
  325. Weinstein MC, Pearlman LA. Cost-effectiveness of automated multichannel chemistry analyzers. Case study #4. The Implications of Cost-Effectiveness Analysis of Medical Technologies. Office of Technology Assessment. 1981.
  326. Weinstein MC. Economic assessments of health technologies. U.S. Department of Health and Human Services. Pub. No. (PHS) 81-1214. 1981.
  327. Koplan JP, Fraser DW, Schoenbaum SC, Weinstein MC. Benefits and risks of pertussis vaccine: further comments. N Engl J Med. 1980 Nov 27; 303(22):1301-2.
    View in: PubMed
  328. Weinstein MC. Estrogen use in postmenopausal women--costs, risks, and benefits. N Engl J Med. 1980 Aug 7; 303(6):308-16.
    View in: PubMed
  329. Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology. 1980 Feb; 87(2):109-21.
    View in: PubMed
  330. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR, McNeil BJ. Clinical Decision Analysis. 1980.
  331. Weinstein MC, Sherman H. A structured framework for policy intervention to improve health resource allocation. Issues in Health Care Regulation. (Gordon RS, Ed.). 1980.
  332. Weinstein MC. Cost-effectiveness analysis for clinical procedures in oncology. Bull Cancer. 1980; 67(5):491-500.
    View in: PubMed
  333. Weinstein MC, Shepard DS, Pliskin JS. The economic value of changing mortality probabilities. The Quarterly Journal of Economics. 1980; 95:373-396.
  334. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status: theory and application. Operations Research. 1980; 28:206-224.
  335. Koplan JP, Schoenbaum SC, Weinstein MC, Fraser DW. Pertussis vaccine--an analysis of benefits, risks and costs. N Engl J Med. 1979 Oct 25; 301(17):906-11.
    View in: PubMed
  336. Laird NM, Weinstein MC, Stason WB. Sample-size estimation: a sensitivity analysis in the context of a clinical trial for treatment of mild hypertension. Am J Epidemiol. 1979 Apr; 109(4):408-19.
    View in: PubMed
  337. Weinstein MC. Economic evaluation of medical procedures and technologies: progress, problems, and prospects. Medical Technology. (Wagner J, Ed.) U.S. Department of Health, Education, and Welfare Publication No. (PHS) 79-3254. 1979.
  338. Weinstein MC. Decision making for toxic substance control: cost-effective information development for the control of environmental carcinogens. Public Policy. 1979; 27:333-383.
  339. Nair SR, Cherubin CE, Weinstein M. Penetration of cefoxitin into cerebrospinal fluid and treatment of meningitis caused by gram-negative bacteria. Rev Infect Dis. 1979 Jan-Feb; 1(1):134-43.
    View in: PubMed
  340. Weinstein MC. Prevention that pays for itself. N Engl J Med. 1978 Aug 10; 299(6):307-8.
    View in: PubMed
  341. Weinstein MC, Stason WB. Economic considerations in the management of mild hypertension. Ann N Y Acad Sci. 1978 Mar 30; 304:424-40.
    View in: PubMed
  342. Nichols AL, Weinstein MC. Optimal resource allocation in community hypertension programs. Management Science. 1978; 27:1536-1537.
  343. Weinstein MC, Fineberg HV. Cost-effectiveness analysis for medical practices: appropriate laboratory utilization. Logic and Economics of Clinical Laboratory Use. (Benson ES, Rubin M, Eds.). 1978.
  344. Cropper ML, Weinstein MC, Zeckhauser R. The optimal consumption of depletable natural resources: an elaboration, correction, and extension. The Quarterly Journal of Economics. 1978; 92:337-344.
  345. Gillum RF, Stason WB, Weinstein MC. Screening for hypertension: a rational approach. J Community Health. 1978; 4(1):67-72.
    View in: PubMed
  346. Weinstein MC, Stason WB. Allocating resources: the case of hypertension. Hastings Cent Rep. 1977 Oct; 7(5):24-9.
    View in: PubMed
  347. Stason WB, Weinstein MC. Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension. N Engl J Med. 1977 Mar 31; 296(13):732-9.
    View in: PubMed
  348. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977 Mar 31; 296(13):716-21.
    View in: PubMed
  349. Raiffa H, Schwartz WB, Weinstein MC. Evaluating health effects of societal decisions and programs. Decision Making in the Environmental Protection Agency. 1977.
  350. Weinstein MC, Pliskin JS, Stason WB. Coronary artery bypass surgery: decision and policy analysis. Costs, Risks, and Benefits of Surgery. (Bunker JP, Barnes BA, Mosteller F, Eds.). 1977.
  351. Weinstein M, Tyrrell B, Newton TH. The sella turcica in Nelson's syndrome. Radiology. 1976 Feb; 118(2):363-5.
    View in: PubMed
  352. Weinstein MC, Stason WB. Hypertension: A Policy Perspective. 1976.
  353. Weinstein MC, Zeckhauser R. Use patterns for depletable and recyclable resources. The Review of Economic Studies Symposium. 1975; 67-88.
  354. Weinstein MC, Zeckhauser R. The optimal consumption of depletable natural resources. The Quarterly Journal of Economics. 1975; 89:371-392.
  355. Weinstein MC. Allocation of subjects in medical experiments. N Engl J Med. 1974 Dec 12; 291(24):1278-85.
    View in: PubMed
  356. Zeckhauser R, Weinstein MC. The topology of Pareto-optimal regions with public goods. Econometrica. 1974; 42:643-666.
  357. Cook AJ, Weinstein M, Powell RD. Diffuse amyloidosis of the tracheobronchial tree. Bronchographic manifestations. Radiology. 1973 May; 107(2):303-4.
    View in: PubMed
  358. Weinstein MC. Bringing the Outside Inside: Government Decision Making for the Environment. 1973.
  359. Weinstein MC, Zeckhauser R. Critical ratios and efficient allocation. Journal of Public Economics. 1973; 2:147-157..
  360. Weinstein MC, Clark ID. Emissions measurement and the testing of new vehicles. Clearing the Air. (Jacoby HD, Steinbruner JD, Eds.). 1973.
  361. Soto RJ, Codevilla AH, Weinstein M, Rozados I, Rabinovich L, Goldberg D. Adaptive mechanisms to iodine deficiency in endemic goiter in Misiones, Argentina. Metabolism. 1968 Apr; 17(4):326-35.
    View in: PubMed
  362. Soto RJ, Rozados IB, Codevilla A, Weinstein M, Rabinovich L, Goldberg D, Sartorio G. [Endemic goiter in the Provincia de Misiones (Argentina)]. Rev Argent Endocrinol Metab. 1965 Sep-Dec; 11(3):93-112.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu). HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Weinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_